All Stories

  1. A novel inactivated oral rabies vaccine with the incorporation of U-OMP19 enhances the immunogenicity by reducing viral proteins degradation and activating dendritic cells in a mouse model
  2. Z-Ligustilide restricts rabies virus replication by inducing ferroptosis through the ACSL4-LPCAT3-POR pathway
  3. CXCL13 promotes broad immune responses induced by circular RNA vaccines
  4. Generation of canine neutralizing antibodies against canine parvovirus by single B cell antibody technology
  5. AP3B1 facilitates PDIA3/ERP57 function to regulate rabies virus glycoprotein selective degradation and viral entry
  6. A cocktail of engineered chimeric antibodies targeting the central nervous system produces a broad-spectrum therapeutic effect for symptomatic rabies
  7. RTP4 restricts lyssavirus rabies infection by binding to viral genomic RNA
  8. hnRNPAB inhibits Influenza A virus infection by disturbing polymerase activity
  9. Focus on pet diseases
  10. Lassa virus Z protein hijacks the autophagy machinery for efficient transportation by interrupting CCT2-mediated cytoskeleton network formation
  11. Lyssavirus matrix protein inhibits NLRP3 inflammasome assembly by binding to NLRP3
  12. Rapid diagnosis of canine respiratory coronavirus, canine influenza virus, canine distemper virus and canine parainfluenza virus with a Taqman probe-based multiplex real-time PCR
  13. TLR9 promotes monocytic myeloid-derived suppressor cell induction during JEV infection
  14. Investigation of the epidemiology, pathogenicity and immunogenicity of Bordetella bronchiseptica isolated from cats and dogs in China from 2021 to 2023
  15. A broadly applicable protein-polymer adjuvant system for antiviral vaccines
  16. The matrix protein of lyssavirus hijacks autophagosome for efficient egress by recruiting NEDD4 through its PPxY motif
  17. Neuroinvasive virus facilitates viral replication by employing lipid droplets to reduce arachidonic acid-induced ferroptosis
  18. Lyssavirus M protein degrades neuronal microtubules by reprogramming mitochondrial metabolism
  19. TRIM72 restricts lyssavirus infection by inducing K48-linked ubiquitination and proteasome degradation of the matrix protein
  20. Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani
  21. Cholesterol depletion inhibits rabies virus infection by restricting viral adsorption and fusion
  22. A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs
  23. Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses
  24. A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs
  25. Yeast Peptides Improve the Intestinal Barrier Function and Alleviate Weaning Stress by Changing the Intestinal Microflora Structure of Weaned Lambs
  26. Transdermal delivery of Fluoropolymer-Modified microneedle vaccines against rabies elicits potent humoral immunity
  27. TRIM72 restricts lyssavirus infection by inducing K48-linked ubiquitination and proteasome degradation of the matrix protein
  28. The CH24H metabolite, 24HC, blocks viral entry by disrupting intracellular cholesterol homeostasis
  29. Short-Chain Fatty Acids Alleviate Vancomycin-Caused Humoral Immunity Attenuation in Rabies-Vaccinated Mice by Promoting the Generation of Plasma Cells via Akt-mTOR Pathway
  30. Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1
  31. A novel epitope tag from rabies virus has versatile in vitro applications
  32. Interleukin-1β suppresses rabies virus infection by activating cGAS-STING pathway and compromising the blood-brain barrier integrity in mice
  33. Resistin secreted by porcine alveolar macrophages leads to endothelial cell dysfunction during Haemophilus parasuis infection
  34. Substitution of S179P in the Lyssavirus Phosphoprotein Impairs Its Interferon Antagonistic Function
  35. Trim25 restricts rabies virus replication by destabilizing phosphoprotein
  36. Regulation of innate immune responses by rabies virus
  37. Lab-Attenuated Rabies Virus Facilitates Opening of the Blood-Brain Barrier by Inducing Matrix Metallopeptidase 8
  38. A single dose of recombinant VSV-RABVG vaccine provides full protection against RABV challenge
  39. Dual-Mode Immunosensor for Electrochemiluminescence Resonance Energy Transfer and Electrochemical Detection of Rabies Virus Glycoprotein Based on Ru(bpy)32+-Loaded Dendritic Mesoporous Silica Nanoparticles
  40. Meningeal lymphatic vessels mediate neurotropic viral drainage from the central nervous system
  41. Binding induced isothermal amplification reaction to activate CRISPR/Cas12a for amplified electrochemiluminescence detection of rabies viral RNA via DNA nanotweezer structure switching
  42. Effective cross-protection of a lyophilized live gE/gI/TK-deleted pseudorabies virus (PRV) vaccine against classical and variant PRV challenges
  43. lncRNA EDAL restricts rabies lyssavirus replication in a cell-specific and infection route-dependent manner
  44. Comprehensive Analysis of Protein Acetylation and Glucose Metabolism in Mouse Brains Infected with Rabies Virus
  45. G protein-coupled receptor 17 restricts rabies virus replication via BAK-mediated apoptosis
  46. Lipid Droplets Are Beneficial for Rabies Virus Replication by Facilitating Viral Budding
  47. A spatial and cellular distribution of rabies virus infection in the mouse brain revealed by fMOST and single‐cell RNA sequencing
  48. Overexpression of Interleukin-33 in Recombinant Rabies Virus Enhances Innate and Humoral Immune Responses through Activation of Dendritic Cell-Germinal Center Reactions
  49. Toll-Like Receptor 4 Regulates Rabies Virus-Induced Humoral Immunity through Recruitment of Conventional Type 2 Dendritic Cells to Lymph Organs
  50. Colloidal Manganese Salt Improves the Efficacy of Rabies Vaccines in Mice, Cats, and Dogs
  51. PABPC4 Broadly Inhibits Coronavirus Replication by Degrading Nucleocapsid Protein through Selective Autophagy
  52. The role of interferon regulatory factor 7 in the pathogenicity and immunogenicity of rabies virus in a mouse model
  53. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model
  54. Preexposure and Postexposure Prophylaxis of Rabies With Adeno-Associated Virus Expressing Virus-Neutralizing Antibody in Rodent Models
  55. Murine Ifit3 restricts the replication of Rabies virus both in vitro and in vivo
  56. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?
  57. Aptamer and RVG functionalized gold nanorods for targeted photothermal therapy of neurotropic virus infection in the mouse brain
  58. Comparison of lncRNA and mRNA expression in mouse brains infected by a wild-type and a lab-attenuated Rabies lyssavirus
  59. Early diagnosis of rabies virus infection by RPA-CRISPR techniques in a rat model
  60. Development of A Super-Sensitive Diagnostic Method for African Swine Fever Using CRISPR Techniques
  61. A novel oral rabies vaccine enhances the immunogenicity through increasing dendritic cells activation and germinal center formation by expressing U-OMP19 in a mouse model
  62. P38 mitogen-activated protein kinase promotes Wnt/β-catenin signaling by impeding Dickkofp-1 expression during Haemophilus parasuis infection
  63. Isolation and evolutionary analyses of porcine epidemic diarrhea virus in Asia
  64. Interferon-Inducible GTPase 1 Impedes the Dimerization of Rabies Virus Phosphoprotein and Restricts Viral Replication
  65. Different rabies outbreaks on two beef cattle farms in the same province of China: Diagnosis, virus characterization and epidemiological analysis
  66. A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation
  67. Composition of the murine gut microbiome impacts humoral immunity induced by rabies vaccines
  68. A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies replicon
  69. Pomegranate-Inspired Silica Nanotags Enable Sensitive Dual-Modal Detection of Rabies Virus Nucleoprotein
  70. Dual Role of Toll-Like Receptor 7 in the Pathogenesis of Rabies Virus in a Mouse Model
  71. Interferon-λ Attenuates Rabies Virus Infection by Inducing Interferon-Stimulated Genes and Alleviating Neurological Inflammation
  72. Recombinant Rabies Virus Overexpressing OX40-Ligand Enhances Humoral Immune Responses by Increasing T Follicular Helper Cells and Germinal Center B Cells
  73. Dual-mode amplified detection of rabies virus oligonucleotide via Y-shaped DNA assembly
  74. Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines
  75. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production
  76. Cholesterol 25-hydroxylase suppresses rabies virus infection by inhibiting viral entry
  77. Codon optimization of G protein enhances rabies virus-induced humoral immunity
  78. A Recombinant Rabies Virus Expressing Fms-like Tyrosine Kinase 3 Ligand (Flt3L) Induces Enhanced Immunogenicity in Mice
  79. A recombinant canine distemper virus expressing interleukin-7 enhances humoral immunity
  80. Toll-Like Receptor 7 Enhances Rabies Virus-Induced Humoral Immunity by Facilitating the Formation of Germinal Centers
  81. Exhaustive Exercise Does Not Affect Humoral Immunity and Protection after Rabies Vaccination in a Mouse Model
  82. Lab-Attenuated Rabies Virus Causes Abortive Infection and Induces Cytokine Expression in Astrocytes by Activating Mitochondrial Antiviral-Signaling Protein Signaling Pathway
  83. Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine
  84. Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice
  85. An optimized HMGB1 expressed by recombinant rabies virus enhances immunogenicity through activation of dendritic cells in mice
  86. The nucleocapsid proteins of mouse hepatitis virus and severe acute respiratory syndrome coronavirus share the same IFN-β antagonizing mechanism: attenuation of PACT-mediated RIG-I/ MDA5 activation
  87. The ectodomain of rabies virus glycoprotein determines dendritic cell activation
  88. TLR7 Deficiency Leads to TLR8 Compensative Regulation of Immune Response against JEV in Mice
  89. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination
  90. A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells
  91. Recombinant rabies virus expressing IL-21 enhances immunogenicity through activation of T follicular helper cells and germinal center B cells
  92. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein
  93. Structural basis for the dimerization and substrate recognition specificity of porcine epidemic diarrhea virus 3C-like protease
  94. Crystal structure of the mouse hepatitis virus ns2 phosphodiesterase domain that antagonizes RNase L activation
  95. Rabies virus phosphoprotein interacts with ribosomal protein L9 and affects rabies virus replication
  96. Critical Role of K1685 and K1829 in the Large Protein of Rabies Virus in Viral Pathogenicity and Immune Evasion
  97. λ-Carrageenan P32 Is a Potent Inhibitor of Rabies Virus Infection
  98. Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs
  99. Comparison of complete genome sequences of dog rabies viruses isolated from China and Mexico reveals key amino acid changes that may be associated with virus replication and virulence
  100. 244
  101. Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity
  102. Cell-Type-Specific Activation of the Oligoadenylate Synthetase-RNase L Pathway by a Murine Coronavirus
  103. O030 Evasion of the OAS-RNase L pathway by murine coronavirus ns2 protein is required for viral replication and hepatitis
  104. Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
  105. Cell-Type-Specific Type I Interferon Antagonism Influences Organ Tropism of Murine Coronavirus
  106. Expression of MIP-1α (CCL3) by a Recombinant Rabies Virus Enhances Its Immunogenicity by Inducing Innate Immunity and Recruiting Dendritic Cells and B Cells
  107. The Roles of Chemokines in Rabies Virus Infection: Overexpression May Not Always Be Beneficial
  108. Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection
  109. Faculty of 1000 evaluation for Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.
  110. Faculty of 1000 evaluation for Plasmacytoid dendritic cells control T-cell response to chronic viral infection.